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The Monarch Chemistry system, a centrifugal analyser incorporat-
ing sophisticated roboticsfor analytical rotor transfer andJlexible
softwarefor workload scheduling, has been evaluated. The optical
system is capable ofmonitoring absorbance, fluorescence and light
scattering reactions. In addition, an ion selective electrode unit may
be incorporated for the measurement of sodium, potassium and
chloride.
The precision, accuracy, linearity, calibration stability and
carry-over were investigated for 19 routine chemistries. The
within-batch and between-day precision data were good in the
majority ofcases; some chemistries demonstratedpoor performance
at low analyte concentrations. Method comparison studies showed
good agreement, with small discrepancies being due to different
calibration material and methodological differences. Major dis-
crepancies were found with CK and LD; linearity studies were
good in all cases, except calcium. No significant sample or reagent
carry-over was found.
Assessment of throughput for a variety of test profiles varied
between 300 and 605 tests per hour.
The instrument was easy to operate, very flexible and capable of
handling a large and varied workload.
Introduction
The centrifugal analyser was first described by Dr
Norman Anderson in 1969 [1]. The first commercial
instrument was released in 1978 and since then several
instruments have been developed based on this technol-
ogy [2]. The recent development of the Monarch
chemistry analyser features a number ofnew innovations
in line with predictions made by Tiffany [3]. To virtually
eliminate operator intervention, the analyser incorpor-
ates a transport arm to transfer analytical rotors from the
feed-stack through loading, analysis and finally to the
discard stack. The optical system is capable of changing
optical filters in less than 5 s, enabling more than one
chemistry to be run within the same rotor. In addition,
the system provides a sophisticated software package
which includes an intelligent work scheduling system.
Materials and methods
The instrument
The Monarch is a single free-standing unit requiring a 13
amp power supply; diluent and waste bottles are self-
contained within the system. The instrument is capable of
performing up to a maximum of 24 tests per sample. An
optional ISE unit allows the measurement of sodium,
potassium and chloride, which are always made together.
The sample throughput for a variety ofchemistry profiles
varies between 300 and 605 tests per hour. Stat requests
can be processed at any time during a routine run; when
completed the instrument returns to the original request.
The optical system allows the measurement by ab-
sorbance, fluorescence and light-scattering techniques.
Either rate or end-point assays, with up to four reagent
additions, can be monitored.
Samples and reagents are housed in a compartment
maintained at a temperature of 15C for greater reagent
stability. Reagent boats are identified by a bar-coded
label which is read by an optical bar-code sensor.
Sample and reagent are loaded into a disposable UVT
rotor via two stainless-steel pipette tips attached to the
pipette arm. Each rotor contains 39 cuvettes into which
sample (89 1 maximum) and reagent (100-236 1) are
dispensed. The pipette arm is located in a thermal box,
allowing movement between the reagent compartment
and analysis compartment. The instrument uses two
diluent-filled syringes to load the rotor. During loading
the syringes are drawn down, resulting in sample and
reagent being taken up into the tubing connected to the
pipette tips. After sampling, the pipette arm moves back
to the home position and sample and reagent are
dispensed into the rotor. The pipette arm is heated to the
same temperature as the analysis compartment (25, 30 or
37 C).
The analysis compartment contains a robotic transport
arm surrounded by a feed-stack, a loading table, analysis
table and discard/park table. The feed-stack contains a
supply of clean rotors. The optics module contains the
tungsten and xenon lamps, a scanning monochromator
and sets of mirrors, lenses and optical windows.
Wavelengths between 340 and 690 nm can be selected.
The analytical performance of the Monarch was assessed
for 19 different analytes. The aspects evaluated included
within-day and between-day precision at three different
analyte concentrations; calibration stability; method
linearity; relative accuracy and system carry-over [4].
The transport arm transfers the loaded rotor to the
analysis table, where reagents and sample are mixed and
data acquisition takes place. When the analysis is
complete a full rotor is discarded and a partially used
rotor is held on the park station, if possible, for re-use.
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The ISE module is housed independently within the
system. Ion-selective electrodes determine the concentra-
tion ofsodium, potassium and chloride in plasma, serum,
urine or sweat. The sample is diluted, mixed and then
drawn into the electrode module, which contains the
sodium, potassium, chloride and reference assemblies.
The analyser is controlled by a computer with which the
operator communicates via a keyboard and VDU. Two
disks store test parameters, response data, results, user
file data, utilities and diagnostic information.
The software contains a number of features which allow
the user to review, edit and print information. Each test
has a corresponding parameter table which may be
readily accessed by the user. New tests may also be
created in this way.
The workload may be scheduled in one of two ways-
either time-optimized or patient priority. In time-opti-
mized mode the instrument schedules the request for
optimum throughput by analysing batches ofchemistries
together. This is the most time-efficient and economical
mode of operation. In patient priority mode, the system
will schedule to analyse the tests sample by sample.
To increase the efficiency of the instrument and allow
more than one chemistry to be run on one rotor, tests are
assigned to a compatibility class. For tests to be in the
same compatibility class the main characteristics of the
class must be the same.
Analytical methods and reagents
Details of the methods employed in the evaluation are
shown in table 1. All reagents were prepared and used
according to the manufacturers’ recommendations. The
calibrators used were RefIL A, B, C (Instrumentation
Laboratory) and for the calibration of BCP albumin,
Nycomed Reference Material. A range of quality-control
sera were used: Serachem Level I and II (Fisher
Diagnostics), Technicon Reference (Technicon Instru-
ments), Autonorm Low and High (Nycomed) and
Precinorm E and Precipath E (Boehringer Mannheim)
Precision
The within-batch precision was assessed by analysing
control sera at three different analyte concentrations.
Eighteen samples of each control sera were assayed, thus
ensuring that all samples would be analysed within one
rotor. This was carried out using the instrument in both
’time-optimized’ and ’patient-priority’ mode.
The between-batch precision was assessed over a period
of 20 working days. Quality-control material was recon-
stituted at the beginning of each day.
Calibration stability
The instrument was calibrated at the start of each day,
according to the manufacturers’ recommendations. Cali-
brators and control sera were then assayed immediately
following calibration and at the end of each day.
Linearity
Samples known to contain high levels of analyte were
diluted in varying proportions with 60 g/1 BSA. Where
this was not possible a commercial lyophilized quality
control material was reconstituted in a smaller volume
than recommended to give elevated analyte concentra-
tions. For the electrolytes, a stock solution of sodium
Table 1. Details ofmethods employed on Monarch and comparison system.
Sample volume
Analyte (tl) Principle ofMonarch method Comparison method
Sodium }
Potassium 30
Chloride
TCO2 3
Glucose 3
Urea 3
Creatinine 9
Total protein 5
Albumin 3
Calcium 5
Phosphate 4
Bilirubin 8
ALP 10
ALT 20
CK 10
LD 5
Urate 20
Cholesterol 3
Triglyceride 3
ISE
Enzymatic, phosphoenolpyruvate
carboxylase
Hexokinase, glucose-6-phosphate
dehydrogenase
Urease/GLDH
Picric acid
Biuret
Bromocresol purple
Cresolphthalein complexone
Ammonium molybdate
Sulphanilic acid
p-nitrophenyl phosphate with DEA
buffer
L-alanine, 0-ketoglutarate
Creatine phosphate
Pyruvate --
lactate
Uricase, 340 nm
Cholesterol oxidase
Lipase, glycerophosphate oxidase
Flame photometry
(Na, K only) SMAII
Indicator dye, SMAII
Glucose oxidase SMAII
Diacetyl monoxime SMAII
Jaffe SMAII
Biuret SMAII
Bromocresol purple SMAII
Cresolphthalein complexone SMAII
Phosphomolybdate, SMAII
Jendrassik and Grof, SMAII
p-nitrophenyl phosphate withAMP
buffer, SMAII
L-alanine optimized SMAII
Creatine phosphate,
Multistat III
Pyruvate lactate, Multistat III
Uricase 340 nm, RA1000
Cholesterol oxidase, RA1000
Lipase, glycerophosphate oxidase
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chloride was used for sodium and chloride and a solution
of potassium chloride for potassium. Further dilutions of
the stock were made in deionized water.
Table 2. Within-batch precision at three analyte concentrations.
Results for time-optimized and patient-prioritized mode (in
parentheses).
Accuracy
At least 100 patient samples were analysed on the
Monarch and the results compared to those obtained in
the routine laboratory. Details of comparison methods
are given in table 1.
CarTy-over
The design of the instrument required investigation of
both ’sample to sample’ carry-over and ’reagent to
sample or reagent’ carry-over.
Sample to sample carry-over
Three sequences of a high pool followed by a low pool
were assayed for each analyte. The mean carry-over was
calculated for each sequence usiiag the formula:
L1 La
Hs- Ls
100 (%)
Reagent to sample or reagent carry-over
A mid-level human serum pool was assayed, in triplicate,
such that, ultimately each chemistry had been preceded
and followed by the other. The coefficient ofvariation for
the analyte being investigated was then calculated.
Results and discussion
Precision
Results for the within-batch and between-day precision
are shown in tables 2 and 3 respectively.
The results for the within-batch precision shows good
performance in the majority of cases. The disappointing
precision obtained at low levels of urea, ALT and
triglyceride may be due to the low absorbance changes for
these assays. Generally, the precision obtained whilst
scheduling the instrument in ’patient-priority’ mode was
inferior to that found in time-optimized mode. This may
be due to each test having its own blank in patient-
priority mode, as opposed to one blank for a batch of tests
in time-optimized mode.
The day-to-day precision was found to be acceptable,
with the exception of creatinine, calcium, CK and
triglyceride, which were disappointing. The performance
of the TCO2 method was disappointing throughout the
concentration range.
There was a definite improvement in the precision
obtained for CK and LD when using alternative quality-
control material.
The performance of the ISE unit was very good.
Analyte Mean SD CV(%) CV (%)
Sodium (mmol/1) 123"6 0’88 0"72 (0"34)
139.1 0.66 0.48 (0.49)
147.9 0.59 0.40 (0.37)
Potassium (mmol/1) 1"90 0"00 0"00
4.30 0.00 0.00 (1.18)
6.53 0.05 0.69 (0.76)
Chloride (mmol/1) 91"0 0"56 0"62 (0’29)
98.7 0.38 0.38 (0.46)
116.5 0.36 0.31 (0.37)
TCO2 (mmol/1) 15"8 0"39 2"47 (3"72)
25’4 0’39 1.55 (4"71)
27"2 0"67 2"47 (4-57)
Glucose (mmol/1) 4"09 0"04 1"07 (1"96)
12"30 0"14 1"12 (2"17)
19.79 0.20 1.01 (1.86)
Urea (mmol/1) 5"52 0"20 3"55 (3"94)
18"22 0"26 1"42 (2"79)
19.11 0.35 1.19 (3.68)
Creatinine (tmol/1) 101"9 2"06 2"02 (3’01)
452"6 4"10 0"91 (2"21)
713"8 5"25 0’74 (2"40)
Total protein (g/l) 40"9 O’48 1"17 (2.58)
67.6 0.78 1.15 (2.05)
Albumin (g/l) 24’3 0"34 1"42
38.0 0.23 0.60 (1.68)
49.2 0.25 0.51 (1.29)
Calcium (mmol/l) 1"02 0"02 1"63
2.42 0.03 1.63
3.19 0.02 0.66 (1.38)
Phosphate (mmol/1) 1"17 0"02 1"36 (3"16)
1’67 0"02 1"04 (2"49)
2"84 0"02 0"70 (2"48)
T Bilirubin (tmol/1) 11"9 0"24 2’01 (2"23)
64"9 2"61 4"03 (3"20)
147.7 0.61 0.41 (1.38)
ALP (I.U./1) 74.3 0.98 1.32 (3.49)
170.8 1.39 0.81 (2.11)
644.7 6.00 0.93 (1.66)
ALT (I.U./1) 17.7 0.72 4.06 (6.12)
74.7 0.81 1.09 (1.67)
189.0 1.10 0.58 (1.86)
CK (I.U./1) 121.2 1.59 1.31 (1.88)
45.6 3.08 .25
411.4 6.56 1.59 (7.88)
LD (I.U./1) 228.9 4.85 2.12 (3.49)
370.4 5.76 1.55
622.4 5.54 0.89 (1.76)
Urate (tmol/1) 200"8 2" 16 1"07 (1’76)
327"0 5"98 1"48
588"0 2"29 0"39 (1"10)
Cholesterol (mmol/1) 2"56 0"03 1"23 (2"54)
4"83 0"06 1’32 (2"88)
5.82 0-07 1.22
Triglyceride (mmol/1) 0"26 0"015 5"71 (14"2)
0"78 0"040 5"10
2.23 0.040 1.82
Calibration stability
Assaying quality control material at the beginning and
end of each day showed deterioration in the performance
ofsome analytes. In these cases more frequent calibration
may be required.
Reviewing the absorbance data obtained for each of the
calibrators over the period of the evaluation showed
significant variation in absorbance for TCO2, urea and
calcium.
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Table 3. Between-batch precision at three analyte concentrations
for controls analysed immediately following calibration. Results
for controls analysed in the afternoon are given in parentheses.
Analyte Mean SD CV(%) CV (%)
Sodium (mmol/1) 123"4 1’ 14 0"92 (1"00)
140.6 1.65 1.17 (0.88)
150.0 1.45 0.97 (1.05)
Potassium (mmol/1) 1"90 0"00 0"00 (0"00)
4"30 0"04 0"88 (1"40)
6"59 0"07 1"02 (1"29)
Chloride (mmol/l) 88"0 0"93 1"05 (1"31)
98.9 1.13 1.14 (1.67)
112.1 1.19 1.06 (1-90)
TCO2 (mmol/1) 18.9 1.29 6.90 (10.40)
28.0 1.65 5.91 (8.10)
32.8 2.07 6.32 (9.09)
Glucose (mmol/1) 4"12 0"12 2"56 (2"70)
12"41 0"38 3"09 (2"44)
19-91 0.43 2.16 (2.62)
Urea (mmol/1) 6"03’ 0"19 3"10 (4"02)
19"90 0"58 2-91 (2"88)
29.59 1.14 3.84 (5.15)
Creatinine ([amol/1) 106"3 8"05 7"60 (4.70)
452"8 8"48 1"87 (2"38)
718"1 11"91 1-66 (2"59)
Total protein (g/l) 39"5 0"75 1’90 (2"88)
67"1 1"21 1"81 (2"52)
82"4 1"53 1"85 (1"77)
Albumin (g/l) 24"2 0"44 1"81 (2"63)
38.8 1.10 2.86 (3.19)
49.0 0.46 0.94 (1.80)
Calcium (mmol/1) 1"03 0"058 5"59 (3"48)
2.48 0.042 1.70 (3.07)
3"25 0"050 1.53 (2"93)
Phosphate (mmol/1) 1"11 0"022 1"95 (3"13)
1"64 0’036 2-17 (3-21)
2"72 0"054 1"99 (3"37)
T Bilirubin (mol/1) 10"8 0-83 7-70 (6"70)
60.0 1.50 2.50 (4.00)
149"9 3"72 2"48 (2"64)
ALP (I.U./1) 80.3 2.63 3.27 (3.37)
176.8 5.16 2.92 (2.24)
653.9 15.70 2.40 (2.21)
ALT (I.U./1) 22.7 1.49 6.60 (6.40)
80"3 1"92 2"39 (3"27)
192-3 3.09 1.61 (1.58)
CK (I.U./1) 119-6 0.15 .50 (8.1)
226.1 21.30 9.41 (11.00)
445.8 37.04 8.31 (5.48)
LD (I.g./1) 236.7 7.00 2-97 (3.20)
392"0 16"80 4"28 (3"57)
631"5 20"73 3"28 (3"11)
Urate ([amol/1) 210"0 5"22 2"48 (4"37)
334.3 6.87 2.05 (3.96)
583.0 11.37 1.95 (3.76)
Cholesterol (mmol/1) 2"65 0"079 3"00 (2’85)
4"87 0"116 2"40 (2"40)
6"03 0"150 2"47 (4’29)
Triglyceride (mmol/1) 0"62 0"050 8" 13 (4"39)
2"11 0"097 4"62 (2"99)
5"56 0"190 3"38 (2"78)
Assessing calibration stability by calculation of the
analyte concentration based on day calibration figures
showed a variation of greater than 4SD in the case of
calcium, phosphate, total protein and urate.
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Table 4. Linearity ofassays performed on the Monarch.
Analyte Determined range oflinearity
Sodium 110-160 mmol/l
Potassium 1-10 mmol/1
Chloride 70-140 mmol/1
TCO2 0-45 mmol/1
Glucose 0-30 mmol/1
Urea 0-35 mmol/1
Creatinine 0-1500 tmol/1
Total protein 0-130 g/1
Albumin 0-50 g/l
Calcium 0-2"5 mmol/1
Phosphate 0-4’5 mmol/1
Bilirubin 0-500 tmol/1
ALP 0-1500 IU/1
ALT 0-450 IU/1
CK 0-1000 IU/1
LD 0-750 IU/1
Urate 0-0’9 mmol/1
Cholesterol 0-10"5 mmol/1
Triglyceride 0-10"5 mmol/1
Linearity
The linear range for each analyte is shown in table 4. The
results obtained agreed with the expected ranges for each
analyte, except in the case ofcalcium. The results suggest
that the assay is not linear above 3"0 mmol/1.
Accuracy
The method comparison studies indicated a good agree-
ment in the majority ofcases (table 5 and figure 1). Small
differences were attributable to the use of different
calibration materials. Major discrepancies were found
with amylase and alkaline phosphatase, due to the use of
different methods, and with CK and LD. Experiments
were carried out in an attempt to determine the cause of
Table 5. Linear regression statisticsfor Monarch (y-axis) against
various comparison methods (x-axis).
Correlation
Test N Slope Y-intercept coefficient
Sodium 176 1"126 -16.14 0-987
Potassium 148 0"979 0"357 0"996
TCO2 121 0"925 -4"37 0"837
Glucose 161 0"975 -0.049 0.997
Urea 188 "012 0-60 0"996
Creatinine 170 0"926 25"57 0"997
Total protein 137 0"928 4"33 0"974
Albumin 105 0"933 3"057 0-984
Calcium 139 0"981 0"035 0"962
Phosphate 123 1"025 -0"068 0"980
Total bilirubin 161 0"975 -0.479 0"997
ALP 156 1"571 -0"874 0"989
ALT 145 0"925 -0"057 0"994
CK 161 0"827 0"568 0’999
LD 160 0"725 17"27 0"996
Urate 118 0"935 -0"002 0"985
Cholesterol 141 1"095 0-069 0"990
Triglyceride 114 0"991 -0"04 0"995D.j. Berry and C. P. Price Evaluation of the Monarch chemistry analyser
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Figure 1. Comparison of results for analytes measured on the Monarch (y-axis) and comparison method (x-axis). Details ofcomparison
methods are given in table 1.
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Table 6. Experiment to determine recovery ofaqueous and serum
based sample pipetting on the Monarch.
*Measured Expected Recovery
Sample absorbance absorbance (%)
NADH:
()
6
9
12
0"1863 0"1922 97
0"3602 0"3817 94
0"5367 0"5739 94
0-7184 0-7567 95
Glucose in 60% Albumin:
Concentration
(mmol/1)
5 0.344
10 0"664
15 1"069
0.403 85
0.806 84
1.209 88
* NADH: mean value of five determinations. Glucose: mean
value of three determinations.
Table 7. Sample to sample carry-over on the Monarch.
Mean
Mean high Mean low Mean carry-over
Analyte level (g3) level (L3) Ll-L3 (%)
Sodium (mmol/1) 258" 99"5 0" 0"06
Potassium (mmol/1) 12"8 1"9 0 0
Chloride (mmol/1) 180"8 91"8 1"7 1"9
TCO2 (mmol/1) 57"6 3"8 0"4 0"70
Gtucose (mmol/1) 35"5 2"1 0"1 0"30
Urea (mmol/1) 44"8 2"6 0"2 0"47
Creatinine ([amol/1) 1246 58 3 0"25
Total protein (g/l) 136"8 30"3 0"6 0"56
Albumin (g/l) 42"2 15"5 0"3 1"12
Calcium (mmol/1) 4"29 1"20 0’01 0"32
Phosphate (mmol/l) 5"30 0"34 0"01 0’20
Total bilirubin
(tmol/1) 823 4"8 0"40 0"05
ALP (IU/1) 1200 52 1"00 0"09
ALT (IU/1) 2312 18 5.0 0"22
CK (IU/1) 4000 43 2"0 0"05
LD (IU/1) 1360 103 2"0 0-16
Urate (btmol/1) 1"05 0" 152 0"005 0"56
Cholesterol (mmol/1) 11"08 1"27 0’06 0"61
Triglyceride (mmol/1) 10"0 0"74 0"07 0"76
the discrepancy found with CK and LD assays. Solutions
ofNADH were prepared and loaded by the instrument
using 3, 6, 9 and 1.2 tl sample volumes. The experiment
was also carried out using 5, 10 and 15 mmol/1 glucose in
60% albumin using an end-point glucose dehydrogenase
method adapted to the Monarch. The expected absorb-
ances (determined from the extinction coefficient of
NADH) at 340 nm were confirmed with similar experi-
ments using externally, manually loaded rotors (table 6).
System carry-over
Sample carry-over-the mean carry-over obtained in all
cases was negligible (table 7).
Reagent carry-over-the coefficient of variation obtained
was less than 4SD (mean value obtained in the within-
batch precision study) in all cases except two. The
experiment was therefore repeated using three sequences
of the initial procedures, for CK into creatinine and
triglyceride into LD. No significant carry-over was
detected.
Conclusion
The Monarch chemistry analyser demonstrated good
performance over a wide range of analytes. The coeffi-
cients of variation obtained for the within-batch and
between-day precision data were good, although the
performance of the TCO2 and calcium methods were
disappointing.
The linearity of the methods were sufficiently broad to
allow measurements over a wide range without the
necessity to dilute samples. There was no significant
carry-over.
For the majority ofthe methods calibration would only be
required once a day, and, in many cases, weekly
calibration would be acceptable.
Comparison between the Monarch methods and those
used in the routine laboratory were good in the majority
ofcases. The discrepancy seen in the enzyme results could
not be resolved and it is currently necessary to employ a
factor to correct for the difference.
The Monarch is capable of handling a reasonably large
and varied workload. The work organization of the
instrument is most efficient when batches of tests are
analysed together. In this way a discretionary approach
to testing can be achieved without affecting the perfor-
mance of the instrument. Stat samples can be given
priority at any time during a routine run.
We found the instrument to be flexible and easy to use,
requiring a minimum of training. Only simple main-
tenance procedures were required on a daily, weekly and
monthly basis.
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